Publications

Papers

  1. Hohmann L, Fox BI, Garza KB, Wang CH, Correia C, Curran GM, Westrick SC. Impact of a multi-component educational intervention on community pharmacy-based naloxone services implementation: A pragmatic randomized controlled trial. Annals of Pharmacotherapy. 2023;57(6):677-695. doi: 10.1177/10600280221120405.
  2. Hohmann L, Harris K, Zhao Y, Marlowe K, Phillippe H, Correia C, Fox B. Organizational Readiness to Implement Community Pharmacy-Based Opioid Counseling and Naloxone Services: A Scoping Review of Current Practice Models and Opportunities. Pharmacy. 2023; 11(3):99.
  3. Hohmann L, Phillippe H, Marlowe K, Jeminiwa R, Hohmann N, Westrick SC, Fowler A, Fox BI. A state-wide education program on opioid use disorder: Influential community members’ knowledge, beliefs, and opportunities for coalition development. BMC Public Health. 2022;22:886. doi.org/10.1186/s12889-022-13248-z.

Posters

International

  1. Hohmann L, Fox BI, Phillippe HM, Marlowe KF, Hill S, Fowler A. A community-wide education program on drug addiction: Stakeholder knowledge, beliefs, and opportunities for interprofessional collaboration. Value in Health. 2018;21(S1):S189-S190. Poster at the International Society for Pharmacoeconomics and Outcomes Research 2018 Conference. Baltimore, MD; May 2018.

National

  1. Hohmann L, Fox BI, Phillippe H, Marlowe K, Correia C. Organizational readiness to implement community pharmacy-based opioid counseling and naloxone services: A scoping review. American Journal of Pharmaceutical Education. 2021;85(7): Article 8737. doi.org/10.5688/ajpe8737. Poster presentation at the American Association of Colleges of Pharmacy Annual Meeting; July 2021. Virtual conference.
  2. Hohmann LA, Fox BI, Garza KB, Wang CH, Scott DB, Correia C, Curran GM, Westrick SC. Factors motivating pharmacist participation in community pharmacy-based naloxone services in the Deep South. American Journal of Pharmaceutical Education. 2020;84(6) Article 8220: 830. Poster at the American Association of Colleges of Pharmacy Annual Meeting; Long Beach, CA; July 2020. Virtual conference.
  3. Hohmann LA, Fox BI, Garza KB, Wang CH, Scott DB, Correia C, Curran GM, Westrick SC. Enhancing naloxone services implementation using an educational webinar: A randomized controlled trial in Alabama. Journal of the American Pharmacists Association. 2020;60(3):e1-e240[e222]. Poster accepted for the American Pharmacists Association Annual Meeting and Exposition, National Harbor, MD, March 2020. Virtual Conference. Poster not presented (COVID-19 pandemic).
  4. Hohmann LA, Fox BI, Garza KB, Wang CH, Scott DB, Correia C, Curran GM, Westrick SC. A randomized controlled trial evaluating the impact of a community pharmacy-based naloxone education program. American Journal of Pharmaceutical Education. 2019;83(5) Article 7654:1065. Poster at the American Association of Colleges of Pharmacy Annual Meeting; Chicago, IL; July 2019.
  5. Hohmann LA, Diggs K**, Fox BI, Garza KB, Wang CH, Curran GM, Westrick SC. Empowering community pharmacists to prevent opioid overdose deaths: A qualitative study exploring pharmacists’ needs, attitudes, barriers, and implementation strategies regarding pharmacy-based naloxone services. Journal of the American Pharmacists Association. 2019;59(4):e38-e250[e224]. Poster at the American Pharmacists Association Annual Meeting and Exposition; Seattle, WA; March 2019.

Expert Answers Articles

  1. Expert Answers: Implications of over-the-counter access to opioid antagonist naloxone, Dr. Karen F. Marlowe.
  2. Expert Answers: Opioid epidemic in Alabama, Dr. Brent I Fox.